• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Neuromodulation/Neurostimulation

MicroTransponder reports first commercial implantation of its stroke rehab neurostim system

May 20, 2022 By Chris Newmarker

MicroTransponder (Austin, Texas) recently announced the first commercial implantation of its Vivistim paired VNS system for chronic ischemic stroke rehabilitation. Dr. Charles Y. Liu, director of the University of Southern California Neurorestoration Center, and Dr. Jonathan J. Russin, director of the USC Neuro Revascularization Center, successfully placed the small Vivistim device under the skin of […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Neuromodulation/Neurostimulation, News Well Tagged With: MicroTransponder Inc., Stroke

NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia

May 19, 2022 By Sean Whooley

NeuroMetrix (Nasdaq:NURO) announced today that it received FDA de novo authorization for its Quell neuromodulation device. Quell received the authorization as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity. Quell garnered FDA breakthrough device designation to treat fibromyalgia in July 2021. Much like when it received the breakthrough nod, […]

Filed Under: Business/Financial News, Digital Health, Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Regulatory/Compliance Tagged With: Neurometrix

FDA approves magnetic resonance labeling for CVRx’s Barostim neuromodulation system

May 9, 2022 By Sean Whooley

CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim system. The Barostim neuromodulation system for treating the symptoms of heart failure now includes instructions to allow for safe MRI scans of the head and lower extremities, offering heart failure patients implanted with Barostim more diagnostic options. Minneapolis-based CVRx […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Imaging, Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Regulatory/Compliance Tagged With: cvrx, CVRx Inc., FDA

Axonics raises 2022 sales guidance on Street-beating Q1

May 6, 2022 By Sean Whooley

Axonics Modulation Technologies (Nasdaq:AXNX) reported first-quarter financial results that topped analysts’ consensus forecast. The Irvine, California–based sacral neuromodulation technology developer posted losses of $22.7 million, or 50¢ per share, on sales of $48.4 million for the three months ended March 31, 2022, for a slight bottom-line loss of just over $150,000 year-over-year on sales growth […]

Filed Under: Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, News Well, Wall Street Beat Tagged With: Axonics, Axonics Modulation Technologies

Avanos rises as Q1 earnings match Wall Street projections

May 4, 2022 By Sean Whooley

Avanos Medical (NYSE:AVNS) shares ticked up today on first-quarter results that just about matched the consensus forecast. The Alpharetta, Georgia–based pain management and chronic care device company posted profits of $5.8 million, or 12¢ per share, on sales of $197.4 million for the three months ended March 31, 2022, for a bottom-line gain from losses […]

Filed Under: Business/Financial News, Catheters, Drug Pumps, Drug-Device Combinations, MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Avanos Medical, Avanos Medical (formerly Halyard Health)

Stevanato Group, Bexson expand partnership for wearable drug delivery device

April 29, 2022 By Sean Whooley

Stevanato Group and Bexson Biomedical announced today that they agreed to expand their drug delivery collaboration. Under the agreement, Bexson has access to the use of a customized version of Stevanato’s SG EZ-be Pod wearable delivery system so it can develop new therapeutics for treating an array of mental health conditions, including treatment-resistant depression and post-traumatic stress disorder […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Neurological, Pain Management Tagged With: Bexson Biomedical, stevanato group

Ear-puffing device for migraine treatment wins FDA breakthrough designation

April 28, 2022 By Jim Hammerand

A handheld device that treats migraine attacks with puffs of air in a patient’s ears has been designated a breakthrough device by the FDA. Tempe, Arizona-based Nocira said it is the first company to announce breakthrough device designation for treating migraine attacks in both chronic and non-chronic migraine patients ages 18 and up. The device […]

Filed Under: Blog, Clinical Trials, Featured, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Regulatory/Compliance Tagged With: FDA, migraines, Nocira

Inspire Medical Systems invests in EnsoData and Ognomy

April 28, 2022 By Chris Newmarker

Sleep apnea treatment developer Inspire Medical Systems has invested in two private companies with digital health tech that could better screen people for sleep problems. Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable device that uses neurostimulation to treat obstructive sleep apnea. It made a $10 million minority equity investment in Madison, Wisconsin–based […]

Filed Under: Business/Financial News, Digital Health, Featured, Funding Roundup, Neuromodulation/Neurostimulation, News Well Tagged With: EnsoData, Inspire Medical Systems Inc., Ognomy

18 of the world’s most innovative medical technologies

April 26, 2022 By Danielle Kirsh

Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Diabetes, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Orthopedics, Patient Monitoring, Replacement Heart Valves, Stents, Structural Heart Tagged With: Abbott, Alcon, Biosense Webster, Boston Scientific, Devices4Care, Diatropix, Genmab, Germitec, Hexacath, Johnson & Johnson, Medtronic, Moveo, nanobiotix, Prix Galien International, Siemens Healthineers, sysmex, The Galien Foundation, The Hubrecht Institute, Urgo Medical, VRelax

Medtronic warns on some Percept neurostimulators

April 26, 2022 By Sean Whooley

Medtronic (NYSE:MDT) has issued an urgent field safety notice in Europe regarding its Percept PC implantable neurostimulator (INS). The letter informs users that, in rare instances (0.044%), the Percept PC INS Model B35200 can’t communicate with the clinician programmer and/or the patient programmer system (HH90 Handset and TM91 Communicator). According to the safety notice, in […]

Filed Under: Featured, Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Recalls, Regulatory/Compliance Tagged With: Medtronic

NeuroMetrix revenues rise in Q1

April 26, 2022 By Sean Whooley

NeuroMetrix (Nasdaq:NURO) shares dipped today on first-quarter results that saw losses despite year-over-year revenue growth. The Woburn, Massachusetts–based company posted losses of $958,562, or 14¢ per share, on sales of $2.3 million for the three months ended March 31, 2022, for a bottom-line slide deeper into the red on sales growth of 6.8%. NeuroMetrix’s biggest […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Implants, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Wall Street Beat Tagged With: Neurometrix

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 105
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS